Jonathan Paraskos

INEXAS: A Phase 2 Randomized Trial of On‐demand Inhaled Interferon Beta‐1a in Severe Asthmatics

Christopher McCrae, Marita Olsson, Per Gustafson et al. · Clinical & Experimental Allergy · 2020 · 31 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

AZD3293 A novel BACE1 inhibitor: safety, tolerability, and effects on plasma and CSF Aβ peptides following single- and multiple-dose administration

Robert Alexander, Samantha L. Budd, Muir Russell et al. · Neurobiology of Aging · 2014 · 24 citations

Medicine, Neuroscience, Pharmacology +9

An analytical comparison between point-of-care uric acid testing meters

Jonathan Paraskos, Z. Berke, Jason B. Cook et al. · Expert Review of Molecular Diagnostics · 2015 · 23 citations

Pharmacy, Pharmaceutical Analysis, Biopharmaceutics +10

Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ₄₀and Aβ₄₂following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteers

Angelica Quartino, Gunilla Huledal, Erik Sparve et al. · Clinical Pharmacology in Drug Development · 2014 · 17 citations

Medicine, Pharmacokinetics, Pharmacology +12